Related Experiment Videos
Tissue-type plasminogen activator mutants. Theoretical and clinical considerations
1Lilly Laboratories for Clinical Research, Eli Lilly and Company, Indianapolis, IN.
Circulation
|June 1, 1989
Summary
No abstract available in PubMed .